Recombinant Adenovirus-Mediated Intestinal Trefoil Factor Gene Therapy for Burn-Induced Intestinal Mucosal Injury

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Sun, Yong ^a   Zhu, Yun ^a   Wang, Liangxi ^a   Mao, Xuefei ^a   Peng, Xi ^b   Peng, Yizhi ^b  

^a No 97 Hospital of PLA   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; INTESTINAL TREFOIL FACTOR; PLASMID VECTOR; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BURN; CELL MIGRATION; CELL STRAIN HT29; COLON CANCER; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; GENE EXPRESSION; GENE THERAPY; HOMOLOGOUS RECOMBINATION; IN VITRO STUDY; IN VIVO STUDY; INTESTINE INJURY; INTESTINE MUCOSA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WOUND HEALING;

ADENOVIRIDAE; ANIMALS; BURNS; CELL LINE; CELL MOVEMENT; FEMALE; GENE EXPRESSION; GENETIC THERAPY; GENETIC VECTORS; HT29 CELLS; HUMANS; INTESTINAL MUCOSA; MALE; MICE; PEPTIDES; TRANSDUCTION, GENETIC;

ADENOVIRIDAE; LOTUS;

EID: 84876544307     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062429     Document Type: Article

References (23)

1. Tan XD, Hsueh W, Chang H, Wei KR, Gonzalez-Crussi F, (1997) Characterization of a putative receptor for intestinal trefoil factor in rat small intestine: identification by in situ binding and ligand blotting. Biochem Biophys Res Commun 237: 673-677.
2. Suemori S, Lynch-Devaney K, Podolsky DK, (1991) Identification and characterization of rat intestinal trefoil factor: tissue- and cell-specific member of the trefoil protein family. Proc Natl Acad Sci U S A 88: 11017-11021.
3. Thim L, (1989) A new family of growth factor-like peptides. 'Trefoil' disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP), and frog skin peptides (spasmolysins). FEBS Lett 250: 85-90.
4. Beck PL, Wong JF, Li Y, Swaminathan S, Xavier RJ, et al. (2004) Chemotherapy- and radiotherapy-induced intestinal damage is regulated by intestinal trefoil factor. Gastroenterology 126: 796-808.
5. Sun Y, Wu W, Zhang Y, Lv S, Wang S, et al. (2008) Intestinal trefoil factor produced in Escherichia coli promotes the healing of rat burn-induced acute gastric mucosal lesions. J Trauma 65: 163-169.
6. Auman JT, (2010) Gene therapy: Have the risks associated with viral vectors been solved? Curr Opin Mol Ther 12: 637-638.
7. Tangney M, van Pijkeren JP, Gahan CG, (2010) The use of Listeria monocytogenes as a DNA delivery vector for cancer gene therapy. Bioeng Bugs 1: 284-287.
8. Zhang X, Gao GF, (2010) Revival of gene therapy. Protein Cell 1: 107-108.
9. Patricia MK, Natarajan R, Dooley AN, Hernandez F, Gu JL, et al. (2001) Adenoviral delivery of a leukocyte-type 12 lipoxygenase ribozyme inhibits effects of glucose and platelet-derived growth factor in vascular endothelial and smooth muscle cells. Circ Res 88: 659-665.
10. Lombardi JV, Naji M, Larson RA, Ryan SV, Naji A, et al. (2001) Adenoviral mediated uteroglobin gene transfer to the adventitia reduces arterial intimal hyperplasia. J Surg Res 99: 377-380.
11. Nomura S, Nakamura T, Hashimoto T, Nishio Y, Maegawa H, et al. (2006) MafA differentiates rat intestinal cells into insulin-producing cells. Biochem Biophys Res Commun 349: 136-143.
12. Millar AD, Rampton DS, Chander CL, Claxson AW, Blades S, et al. (1996) Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut 39: 407-415.
13. Podolsky DK, Lynch-Devaney K, Stow JL, Oates P, Murgue B, et al. (1993) Identification of human intestinal trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion. J Biol Chem 268: 6694-6702.
14. Hauser F, Poulsom R, Chinery R, Rogers LA, Hanby AM, et al. (1993) hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus. Proc Natl Acad Sci U S A 90: 6961-6965.
15. Peterson DE, Barker NP, Akhmadullina LI, Rodionova I, Sherman NZ, et al. (2009) Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy. J Clin Oncol 27: 4333-4338.
16. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, et al. (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 95: 2509-2514.
17. Mizuguchi H, Kay MA, (1998) Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method. Hum Gene Ther 9: 2577-2583.
18. Wang JY, McCormack SA, Johnson LR, (1996) Role of nonmuscle myosin II in polyamine-dependent intestinal epithelial cell migration. Am J Physiol 270: G355-362.
19. Kaur P, Potten CS, (1986) Effects of puromycin, cycloheximide and noradrenaline on cell migration within the crypts and on the villi of the small intestine. A model to explain cell movement in both regions. Cell Tissue Kinet 19: 611-625.
20. Efstathiou JA, Noda M, Rowan A, Dixon C, Chinery R, et al. (1998) Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells. Proc Natl Acad Sci U S A 95: 3122-3127.
21. Liu D, el-Hariry I, Karayiannakis AJ, Wilding J, Chinery R, et al. (1997) Phosphorylation of beta-catenin and epidermal growth factor receptor by intestinal trefoil factor. Lab Invest 77: 557-563.
22. Kalabis J, Rosenberg I, Podolsky DK, (2006) Vangl1 protein acts as a downstream effector of intestinal trefoil factor (ITF)/TFF3 signaling and regulates wound healing of intestinal epithelium. J Biol Chem 281: 6434-6441.
23. Jiang YB, Yin QQ, Yang YR, (2009) Effect of soybean peptides on growth performance, intestinal structure and mucosal immunity of broilers. J Anim Physiol Anim Nutr (Berl) 93: 754-760.